Nielsen S M, Toftdahl N G, Nordentoft M, Hjorthøj C
Copenhagen University Hospital, Mental Health Center Copenhagen,Hellerup,Denmark.
Psychol Med. 2017 Jul;47(9):1668-1677. doi: 10.1017/S0033291717000162. Epub 2017 Feb 7.
Several studies have examined whether use of substances can cause schizophrenia. However, due to methodological limitations in the existing literature (e.g. selection bias and lack of adjustment of co-abuse) uncertainties still remain. We aimed to investigate whether substance abuse increases the risk of developing schizophrenia, addressing some of these limitations.
The longitudinal, nationwide Danish registers were linked to establish a cohort of 3 133 968 individuals (105 178 673 person-years at risk), identifying 204 505 individuals diagnosed with substance abuse and 21 305 diagnosed with schizophrenia. Information regarding substance abuse was extracted from several registers and did not include psychotic symptoms caused by substance abuse in the definition. This resulted in a large, generalizable sample of exposed individuals. The data was analysed using Cox regression analyses, and adjusted for calendar year, gender, urbanicity, co-abuse, other psychiatric diagnosis, parental substance abuse, psychiatric history, immigration and socioeconomic status.
A diagnosis of substance abuse increased the overall risk of developing schizophrenia [hazard ratio (HR) 6.04, 95% confidence interval (CI) 5.84-6.26]. Cannabis (HR 5.20, 95% CI 4.86-5.57) and alcohol (HR 3.38, 95% CI 3.24-3.53) presented the strongest associations. Abuse of hallucinogens (HR 1.86, 95% CI 1.43-2.41), sedatives (HR 1.68, 95% CI 1.49-1.90), and other substances (HR 2.85, 95% CI 2.58-3.15) also increased the risk significantly. The risk was found to be significant even 10-15 years subsequent to a diagnosis of substance abuse.
Our results illustrate robust associations between almost any type of substance abuse and an increased risk of developing schizophrenia later in life.
多项研究探讨了使用药物是否会导致精神分裂症。然而,由于现有文献存在方法学局限性(如选择偏倚和未对合并滥用情况进行调整),不确定性依然存在。我们旨在调查药物滥用是否会增加患精神分裂症的风险,以解决其中一些局限性。
将丹麦全国范围内的纵向登记数据相链接,建立了一个由3133968人组成的队列(105178673人年的风险期),识别出204505名被诊断为药物滥用的个体和21305名被诊断为精神分裂症的个体。关于药物滥用的信息从多个登记数据中提取,定义中不包括药物滥用引起的精神病症状。这产生了一个规模大且具有广泛代表性的暴露个体样本。使用Cox回归分析对数据进行分析,并对历年、性别、城市化程度、合并滥用、其他精神疾病诊断、父母药物滥用情况、精神病史、移民情况和社会经济地位进行了调整。
药物滥用诊断增加了患精神分裂症的总体风险[风险比(HR)6.04,95%置信区间(CI)5.84 - 6.26]。大麻(HR 5.20,95% CI 4.86 - 5.57)和酒精(HR 3.38,95% CI 3.24 - 3.53)的关联最为强烈。滥用致幻剂(HR 1.86,95% CI 1.43 - 2.41)、镇静剂(HR 1.68,95% CI 1.49 - 1.90)以及其他药物(HR 2.85,95% CI 2.58 - 3.15)也显著增加了风险。在药物滥用诊断后的10至15年,风险依然显著。
我们的结果表明,几乎任何类型的药物滥用与日后患精神分裂症风险增加之间存在密切关联。